GDIs block activation of RHOC

Stable Identifier
R-HSA-9013108
Type
Reaction [binding]
Species
Homo sapiens
Compartment
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
ARHGDIA is a GDP dissociation inhibitor (GDI) that binds to RHOC and inhibits it (Boulter et al. 2010; Giang Ho et al. 2011). ARHGDIG does not act on RHOC (Zalcman et al. 1996).
Literature References
PubMed ID Title Journal Year
21757538 RhoGDIα-dependent balance between RhoA and RhoC is a key regulator of cancer cell tumorigenesis

Giang Ho, TT, Dubail, J, Deroanne, CF, Lapière, CM, Colige, AC, Nusgens, BV, Stultiens, A

Mol. Biol. Cell 2011
20400958 Regulation of Rho GTPase crosstalk, degradation and activity by RhoGDI1

Burridge, K, Dubash, A, Boulter, E, Brennwald, PJ, Guilluy, C, Rossi, G, Garcia-Mata, R

Nat. Cell Biol. 2010
8939998 RhoGDI-3 is a new GDP dissociation inhibitor (GDI). Identification of a non-cytosolic GDI protein interacting with the small GTP-binding proteins RhoB and RhoG

Honoré, N, Olofsson, B, Camonis, J, Rousseau-Merck, MF, Zalcman, G, Closson, V, Tavitian, A

J. Biol. Chem. 1996
Participants
Participates
Orthologous Events
Authored
Reviewed
Created
Cite Us!